The impact of tumor fragmentation in patients with stage I uterine leiomyosarcoma on patterns of recurrence and oncologic outcome
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 160 (1) , 99-105
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 14 references indexed in Scilit:
- Uterine leiomyosarcoma: A review of the literature and update on management optionsGynecologic Oncology, 2018
- Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2018
- Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture AnalysisEuropean Radiology, 2016
- Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcomaCancer, 2014
- The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcomaGynecologic Oncology, 2011
- A nomogram to predict postresection 5‐year overall survival for patients with uterine leiomyosarcomaCancer, 2011
- Uterine sarcomas: A reviewGynecologic Oncology, 2010
- Uterine Leiomyosarcoma: Does the Primary Surgical Procedure Matter?International Journal of Gynecological Cancer, 2009
- Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign diseaseInternational Journal of Gynecological Cancer, 2008
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988